Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review

  • Kelly L. Stoner
  • Helena Harder
  • Lesley J. Fallowfield
  • Valerie A. Jenkins
Systematic Review

DOI: 10.1007/s40271-014-0075-y

Cite this article as:
Stoner, K.L., Harder, H., Fallowfield, L.J. et al. Patient (2015) 8: 145. doi:10.1007/s40271-014-0075-y

Abstract

Background

Intravenous (IV) drug delivery is commonly used for its rapid administration and immediate drug effect. Most studies compare IV to subcutaneous (SC) delivery in terms of safety and efficacy, but little is known about what patients prefer.

Methods

A systematic review was conducted by searching seven electronic databases for articles published up to February 2014. Included studies were randomized controlled trials (RCTs) and/or crossover designs investigating patient preference for SC versus IV administration. The risk of bias in the RCTs was determined using the Cochrane Collaboration tool. Reviewers independently extracted data and assessed the risk of bias. Any discrepancies were resolved by consensus.

Results

The search identified 115 publications, but few (6/115) met the inclusion criteria. Patient populations and drugs investigated were diverse. Four of six studies demonstrated a clear patient preference for SC administration. Main factors associated with SC preference were time saving and the ability to have treatment at home. Only three studies used study-specific instruments to measure preference.

Conclusions

Results suggest that patients prefer SC over IV delivery. Patient preference has clearly been neglected in clinical research, but it is important in medical decision making when choosing treatment methods as it has implications for adherence and quality of life. If the safety and efficacy of both administration routes are equivalent, then the most important factor should be patient preference as this will ensure optimal treatment adherence and ultimately improve patient experience or satisfaction. Future drug efficacy and safety studies should include contemporaneous, actual patient preference where possible, utilizing appropriate measures.

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Kelly L. Stoner
    • 1
  • Helena Harder
    • 1
  • Lesley J. Fallowfield
    • 1
  • Valerie A. Jenkins
    • 1
  1. 1.Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical SchoolUniversity of SussexBrightonUK

Personalised recommendations